Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies
The management of advanced kidney, bladder, and prostate cancer is rapidly evolving, and new robotic and minimally invasive surgical techniques are now available. This CME program is designed to address the challenges physicians face in treating these complex cases.
Presented by the nationally recognized Fox Chase Cancer Center genitourinary oncology team—comprising experts in urology, radiation therapy, and medical oncology—this program will cover the latest advancements in surgical techniques, radiation therapies, and medical treatments for both localized and advanced bladder, kidney, and prostate cancers.
Program Date
Wednesday, November 20, 2024
Times
5:45 PM – 9 PM
Program Directors
Alexander Kutikov, MD, FACS
Chair and Professor, Department of Urology
Roberta R. Scheller Chair in Urologic Oncology
Fox Chase – Temple Urologic Institute Provider
Daniel M. Geynisman, MD
Chief, Division of Genitourinary Medical Oncology
Associate Professor, Department of Hematology/Oncology
Topics & Presenters:
Single-Port Robotic Surgery for Genitourinary Cancer
Ryan Mark, MD, FACS
Associate Professor, Department of Urology
SABR for Oligometastatic Prostate Cancer and Localized Kidney Cancer
Jessica Karen Wong, MD, MEng
Assistant Professor, Department of Radiation Oncology
Assistant Director, Radiation Oncology Residency and Fellowship Training Program
Nuances and Options for the Management of Advanced Bladder Cancer
Pooja Ghatalia, MD
Assistant Professor, Department of Hematology/Oncology
Collaborating Member, Cancer Epigenetics
Nuclear Dynamics and Cancer Research Program
Biochemically Recurrent Prostate Cancer: Treatment Paradigms and New Options
Fern Anari, MD
Assistant Professor, Department of Hematology/Oncology
Adjuvant therapy in Renal Cell Carninoma
Matthew R. Zibelman, MD
Associate Professor, Department of Hematology/Oncology
Director, Genitourinary Clinical Research
Director of Clinical and Translational Research, GU Service Line
Objectives
After participating in this educational programs, learners should be able to:
- Explain some of the newest surgical techniques for bladder, kidney, and prostate cancer
- Explain the newest data in radiation options for localized and advanced GU malignancies
- Describe new medical options and treatment options for advanced bladder, kidney, and prostate cancer
Inquiries
Lucía Tono, PhD, Med: 215-728-3797
Lucia.Tono-Ramirez@tuhs.temple.edu
Intended Audience
The program is designed for medical, surgical, and radiation oncologists; urologists; radiologists; primary care physicians; fellows; residents; nurses; and other healthcare providers.
Accreditation Statement
The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.
Designation Statement
The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity.